IBM, WellPoint, Inc., and Memorial Sloan Kettering recently unveiled the first commercially developed, Watson-based cognitive computing breakthroughs. These innovations stand to significantly improve the quality and speed of care delivered to patients through individualized, evidence-based medicine. Experts agree that Watson's transformational technologies combined with Memorial Sloan Kettering's cancer analytics and decision-making process has the potential to revolutionize the accessibility of information for the treatment of cancer in communities across the country and around the world.
Mark Kris, MD, Chief of Memorial Sloan Kettering's Thoracic Oncology Service, is available to discuss the ways this next-generation cognitive computing system will improve how medicine is taught, practiced, and paid for.
For more information and to set up an interview, contact the Media Staff.